Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVIPLA-RCT convalescent plasma for early mild COVID-19
jRCTs031200374Completed
- Sponsor
- Health and Labour Sciences Research Grants
- Start
- Feb 2021
- Countries
- 1
01
Overview
Randomised, open-label trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Health and Labour Sciences Research Grants. Primary endpoint: Time-weighted mean change in SARS-CoV-2 viral load from day 0 to day 3 and day 5. Started Feb 2021; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCTs031200374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200374.